Tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate
C17H21ClFN5O2S — CID 155211353
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate
Tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate (PubChem CID 155211353) has the molecular formula C17H21ClFN5O2S and a molecular weight of 413.91 g/mol. Its IUPAC name is tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate |
|---|---|
| PubChem CID | 155211353 |
| Molecular Formula | C17H21ClFN5O2S |
| Molecular Weight | 413.91 g/mol |
| Exact Mass | 413.11 |
| IUPAC Name | tert-butyl 4-(7-chloro-8-fluoro-2-methylsulfanylpyrido[4,3-d]pyrimidin-4-yl)piperazine-1-carboxylate |
| SMILES | CSc1nc(N2CCN(C(=O)OC(C)(C)C)CC2)c2cnc(Cl)c(F)c2n1 |
| InChI | InChI=1S/C17H21ClFN5O2S/c1-17(2,3)26-16(25)24-7-5-23(6-8-24)14-10-9-20-13(18)11(19)12(10)21-15(22-14)27-4/h9H,5-8H2,1-4H3 |
| InChIKey | QPTGWHMQRJQFRL-UHFFFAOYSA-N |
| XLogP | 3.60 |
| TPSA | 71.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.91 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155211353 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.